Collectively, these studies demonstrate that aberrant mTOR signaling activity in skin carcinogenesis and raise inhibiting mTOR signaling as an attractive therapeutic target in skin cancer (Chamcheu et al., 2019). The gene discussed is MTOR; the disease is skin neoplasm.